Our Founder/CEO/CSO, Sareina Wu and Director of Clinical development, Howard Cheng will present our work as invited expert speakers at the 10th Annual CAR-TCR Summit in Boston, US. (September 23-26, 2025)
Speaker:
Sareina Wu, PhD
Chief Executive Officer (GenomeFrontier)
Time:
September 24, 2025 11:00 (GMT-4)
Utilizing Gene Editing & Novel Technologies to Armor Cells & Improve Efficacy
Presentation topic:
Unlocking the Full Potential for Multiplex Gene Therapy with Quantum Engine
- Clinical development of armored CD20/CD19 dual targeting CAR T(SCM) for B-cell malignancy
- Targeting solid cancers with armored triple targeting CAR T(SCM) cells
Speaker:
Howard Cheng, MS
Director of Clinical Development (GenomeFrontier)
Time:
September 24, 2025 14:40 (GMT-4)
Standardizing Clinical Trial Set Up to Increase Pateient Pool & Improve Accuracy of Results
Presentation topic:
Clinical Trials for Cell & Gene Therapies in Asia & Western Settings
- Introduction of Asian regulatory authorities and healthcare systems, focusing on Taiwan
- GenomeFrontier's experience setting the standard for fast-track IND clearance in Taiwan
More information: https://car-tcr-summit.com/